Clinical Trial Update: Mineralocorticoid Use in COVID-19 Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on mineralocorticoid use in COVID-19 patients, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Snippet

Sponsor: Ain Shams University | Conditions: COVID-19, ARDS | Phase 3 | Status: COMPLETED